SANOFI GENZYME
LIVE

Serial Number

79249068

Owner

SANOFI

Attorney

Karen Lim

Filing Date

May 28, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SANOFI GENZYME Trademark

Serial Number: 79249068 • Registration: 5986713

SANOFI GENZYME is a trademark filed by SANOFI on May 28, 2018. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SANOFI (1,107 trademarks)

Paris 75017 , FR

Entity Type: 03

Trademark Details

Filing Date

May 28, 2018

Registration Date

February 18, 2020

Published for Opposition

December 3, 2019

Goods & Services

Education and training relating to health, namely, arranging seminars, conferences and congresses in the field of health care; publication of magazines, books and guides; training relating to health using electronic and digital tools, namely, providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of health care

Custom manufacture of products relating to health, namely, pharmaceuticals and medicines by pharmaceutical compounders

Software relating to health, namely, downloadable computer software for database management in the field of pharmaceutical and medical developments, downloadable software accessible via the internet or mobile phone applications for monitoring and tracking blood glucose levels, downloadable mobile software in the nature of interactive games in the field of healthcare; CD-ROMs featuring information about health; medical imaging software

Telecommunication services, namely, transmission of information by telephone, television, and by computer terminals via Internet sites in the field of health; transmission of information for others relating to health, communication of information for patients or health professionals via computers, via the Internet, television and radio; provision of online chat rooms and online forums for transmission of messages among Internet users concerning health care, medicines and pharmaceutical and medical developments

Pharmaceutical and medicinal preparations for the treatment of cardiovascular diseases and diseases of the central nervous system, cancer, thrombosis, respiratory diseases, lysosomal storage diseases, and for the prevention and treatment of infectious diseases, namely, viral and bacterial infections, sold on prescription or over the counter; sanitary preparations for medical purposes; dietetic food and beverage substances adapted for medical use; pharmaceutical preparation for use as replacement enzyme and for the prevention of adhesion during medical surgeries; reagents for medical diagnosis; chemical preparations for medical and pharmaceutical use, namely, for the treatment of cardiovascular diseases and diseases of the central nervous system, cancer, thrombosis, respiratory diseases, lysosomal storage diseases, rare blood disorders, and for the prevention and treatment of infectious diseases, namely, viral and bacterial infections, sold on prescription or over the counter; vaccines; nutritional supplements; plant extracts for pharmaceutical purposes; pharmacological preparations for skin care

Printed matter, namely, bulletins, magazines, periodicals, books, journals, and posters, all in the field of health

Non-medicinal cosmetic preparations for hygiene, skin care and care; cosmetic preparations

Advice in business, namely, business management advice; advice services, namely, provision of commercial information to the consumer regarding products; advertising and marketing services; distribution services, namely, distribution of products and information on pharmaceutical products for advertising purposes; business administration and management of business affairs in the field of health; promoting public awareness regarding healthcare via printed material

Chemicals for use in the manufacture of pharmaceutical and cosmetic substances and preparations; full line of enzymes for laboratory diagnosis and enzymes for industrial use, not for medical purposes

Consultancy in the field of pharmaceuticals and healthcare; provision of medical information and information relating to health via awareness campaigns

Medical apparatus and instruments, namely, blood glucose monitors, blood glucose monitor kits comprising blood glucose monitors, lancets and control solutions, insulin injectors sold empty, asthma inhalers for medical and therapeutic use sold empty; surgical apparatus and instruments; apparatus for imaging and X-Ray apparatus for medical use; inhalers for therapeutic use sold empty and parts and fittings therefor; devices for the injection of medicines, namely, pens for injection

Scientific and technological services, namely, research in the fields of chemistry, biology and pharmacy, creation and development of software and databases, clinical studies in the nature of chemistry, biology and pharmacy laboratory research in the field of health, engineering services relating to research and development of enzymes and genetics

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 18, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 17, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Jun 6, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 18, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2020 R.PR
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jan 8, 2020 CORV
NEW REPRESENTATIVE AT IB RECEIVED
Dec 27, 2019 NREP
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2019 CRFA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2019 NONP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2019 REAP
ASSIGNED TO LIE
Oct 30, 2019 ALIE
EXAMINERS AMENDMENT MAILED
Oct 23, 2019 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 22, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 22, 2019 XAEC
EXAMINERS AMENDMENT -WRITTEN
Oct 22, 2019 CNEA
ASSIGNED TO EXAMINER
Oct 1, 2019 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 24, 2019 TROA
REFUSAL PROCESSED BY IB
Feb 22, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 1, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 1, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 19, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 18, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 18, 2019 MAFR
ASSIGNED TO EXAMINER
Jan 14, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 3, 2019 REPR